Honestly I think all this while is not easy for Ages also, some might lose confident, some might undervalued. but by valuation still got chance. Hope that management take a wise move as Ages based actually not bad. Those penny stock above, don't said. everyday hit high volume.... lol.
Leonard Ariff Bin Abdul Shatar, Group Managing Director, Duopharma Biotech Bhd
Duopharma Biotech Berhad, the distributor of the Sinopharm vaccine, was one of the winners of the pandemic. But with a price cap set by the government, how will that impact the company? Leonard Ariff Bin Abdul Shatar, Group Managing Director, Duopharma Biotech Bhd answers those questions and their strategy for growth.
As you said , it were long time down trend , but behind this , understand the market sentiment. Construction was long been pull down since mco, same goes to tech and others. Is that showing that is the best chance to invest things that undervalued.